Vaccination is the most effective medical intervention ever introduced and, together with
clean water and sanitation, it has eliminated a large part of the infectious diseases that once …

Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …

Cervical cancer is the third most common cancer in women, with an estimated 529828 new
cases and 275128 deaths reported worldwide in 2008. More than 85% of the global burden …

Cervical cancer is a critical public health issue in sub-Saharan Africa (SSA), where it is the
second leading cause of cancer among women and the leading cause of female cancer …

Background Information on human papillomavirus (HPV) type distribution is necessary to
evaluate the potential impact of current and future HPV vaccines. We estimated the relative …

We have entered a transformative period in cancer prevention (including early detection).
Remarkable progress in precision medicine and immune-oncology, driven by extraordinary …

The annual worldwide burden of the preventable disease cervical cancer is more than
530,000 new cases and 275,000 deaths, with the majority occurring in low-and middle …

Therapeutic vaccination with synthetic long peptides (SLP) can be clinically effective against
HPV-induced premalignant lesions; however, their efficiency in established malignant …

Abstract Human papilloma virus (HPV)‐16 is associated with cervical cancers and induces
expression of the E6 and E7 oncogenes. Using a murine cell line that expresses these, the …

Objectives: To elicit information about parents' knowledge, attitudes, and acceptability
toward HPV infection and vaccination of male adolescents in Italy; to identify subgroups of …